ReviewFrontiers in endocrinology2026

Myosteatosis in type 1 diabetes: immunometabolic mechanisms, biomarkers, and therapeutic targets.

Fatema Al-Rashed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.